Results 91 to 100 of about 1,772,484 (313)

A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. [PDF]

, 2015
The unprecedented scale of the Ebola outbreak in West Africa has, as of 29 April 2015, resulted in more than 10,884 deaths among 26,277 cases. Prior to the ongoing outbreak, Ebola virus disease (EVD) caused relatively small outbreaks (maximum outbreak ...
Bento, AI, Donnelly, CA, Ferguson, NM, Mills, HL, Van Kerkhove, MD   +4 more
core   +1 more source

The Interplay of Public Administration and Community Resilience During the COVID‐19 Pandemic—A Rapid Scoping Review

Conflict Resolution Quarterly, EarlyView.
ABSTRACT This rapid scoping review examines the interplay between public administration and community resilience during the COVID‐19 pandemic, focusing on the type of research conducted, emerging themes in resilience studies, and key lessons learned. The findings show that research in the Global North has primarily examined resilience at the city level,
Daniela Gröschke
wiley   +1 more source

An overview of Ebola virus disease

Northern Clinics of Istanbul, 2016
(Uploaded by Plazi for the Bat Literature Project) Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans. Ebola virus (EBOV) is transmitted through contact with blood or body fluids of a person who contracted or died from EVD, contaminated objects like needles and infected animals or bush meat.
Gül Karagöz, Ayten Kadanali
openaire   +3 more sources

Virus-Vectored Ebola Vaccines [PDF]

Acta Naturae, 2017
The Ebola virus disease (EVD) is one of the most dangerous infections affecting humans and animals. The first EVD outbreaks occurred in 1976 in Sudan and Zaire. Since then, more than 20 outbreaks have occurred; the largest of which (2014-2016) evolved into an epidemic in West Africa and claimed the lives of more than 11,000 people. Although vaccination
Alexander L. Gintsburg, Denis Y. Logunov, A. I. Tukhvatulin, V. B. Pantyukhov, Dmitry V. Shcheblyakov, Borisevich Sv, Boris S. Naroditsky, O. L. Voronina, Inna V. Dolzhikova, L. V. Kolobukhina, Alina S. Dzharullaeva, Elizaveta A. Tokarskaya, V. F. Babira, S. I. Syromyatnikova   +13 more
openaire   +3 more sources

A review of strategies used to retain participants in clinical research during an infectious disease outbreak: The PREVAIL I Ebola vaccine trial experience

Contemporary Clinical Trials Communications, 2018
Introduction: This article describes a retrospective review of participant follow-up and retention strategies in the Partnership for Research on the Ebola Virus in Liberia (PREVAIL) I Vaccine Trial.
Sarah Browne, Tarweh Carter, Risa Eckes, Greg Grandits, Melvin Johnson, Irene Moore, Laura McNay   +6 more
doaj  

Identification of Ellagic Acid from Plant Rhodiola rosea L. as an Anti-Ebola Virus Entry Inhibitor

Viruses, 2018
The recent 2014–2016 West African Ebola virus epidemic underscores the need for the development of novel anti-Ebola therapeutics, due to the high mortality rates of Ebola virus infections and the lack of FDA-approved vaccine or therapy that is available ...
Qinghua Cui, Ruikun Du, Manu Anantpadma, Adam Schafer, Lin Hou, Jingzhen Tian, Robert A. Davey, Han Cheng, Lijun Rong   +8 more
doaj   +1 more source

Frequency of instrument, environment, and laboratory technologist contamination during routine diagnostic testing of infectious specimens [PDF]

, 2018
Laboratory testing to support the care of patients with highly infectious diseases may pose a risk for laboratory workers. However, data on the risk of virus transmission during routine laboratory testing conducted using standard personal protective ...
Burnham, Carey-Ann D, CDC Prevention Epicenters Program,, Dubberke, Erik R, Fraser, Victoria J, Hink, Tiffany, Kwon, Jennie H, Shupe, Angela, Wallace, Meghan A, Yarbrough, Melanie L   +8 more
core   +2 more sources

The role of artificial intelligence in pharmacy: Revolutionizing drug development and beyond

Journal of Intelligent Medicine, EarlyView.
This comprehensive review explores the integration of artificial intelligence (AI) in the field of pharmacy, covering advancements in drug discovery, personalized medicine, medication management, and patient care. It synthesizes current research, methodologies, and future prospects, offering insights into how AI technologies are reshaping ...
Usman Shettima Usman, Farogh Ahsan, Muhammad Alanjiro, Saidu Yahaya Bataba, Jibrin Abdullahi Dallatu, Tarique Mahmood, Shahzadi Bano, Jamal Akhtar Ansari, Saba Parveen   +8 more
wiley   +1 more source

Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry

Cell Discovery, 2018
The re-emergence of Zika virus (ZIKV) and Ebola virus (EBOV) poses serious and continued threats to the global public health. Effective therapeutics for these maladies is an unmet need.
Shu Yang, Miao Xu, Emily M. Lee, Kirill Gorshkov, S. Shiryaev, Shihua He, Wei Sun, Yu‐Shan Cheng, Xin Hu, Anil M. Tharappel, Billy Lu, Antonella Pinto, Chen Farhy, Chun-Teng Huang, Zirui Zhang, Wenjun Zhu, Yuying Wu, Yi Zhou, Guang Song, Heng Zhu, K. Shamim, Carles Martínez-Romero, A. García-Sastre, R. Preston, D. Jayaweera, Ruili Huang, Wenwei Huang, M. Xia, A. Simeonov, G. Ming, X. Qiu, A. Terskikh, Hengli Tang, Hongjun Song, Wei Zheng   +34 more
semanticscholar   +1 more source

Vaccines against Ebola virus [PDF]

Vaccine, 2018
We have just witnessed the largest and most devastating outbreak of Ebola virus disease, which highlighted the urgent need for development of an efficacious vaccine that could be used to curtail future outbreaks. Prior to 2014, there had been limited impetus worldwide to develop a vaccine since the virus was first discovered in 1976.
Venkatraman, N, Silman, D, Folegatti, P, Hill, A   +3 more
openaire   +4 more sources